Transplant characteristics
| . | IM cohort . | Historical cohort . |
|---|---|---|
| Donor type, no. (%) | ||
| HLA-identical sibling | 58 (40) | 103 (45) |
| Matched unrelated donor | 81 (56) | 120 (52) |
| HLA mismatch | 1 (1) | 5 (2) |
| Unknown | 5 (3) | 3 (1) |
| Gender mismatch, no. (%) | ||
| Female donor, male recipient | 41 (28) | 63 (27) |
| Other | 104 (72) | 168 (73) |
| Conditioning regimen, no. (%) | ||
| Cy/TBI | 54 (37) | 114 (49) |
| Bu/Cy | 75 (52) | 89 (39) |
| Etoposide/TBI | 9 (6) | 0 |
| Other | 7 (5) | 7 (3) |
| Unknown | 0 | 21 (9%) |
| Stem-cell source, no. (%) | ||
| BM | 55 (38) | 178 (77) |
| PBSC | 90 (62) | 53 (23) |
| . | IM cohort . | Historical cohort . |
|---|---|---|
| Donor type, no. (%) | ||
| HLA-identical sibling | 58 (40) | 103 (45) |
| Matched unrelated donor | 81 (56) | 120 (52) |
| HLA mismatch | 1 (1) | 5 (2) |
| Unknown | 5 (3) | 3 (1) |
| Gender mismatch, no. (%) | ||
| Female donor, male recipient | 41 (28) | 63 (27) |
| Other | 104 (72) | 168 (73) |
| Conditioning regimen, no. (%) | ||
| Cy/TBI | 54 (37) | 114 (49) |
| Bu/Cy | 75 (52) | 89 (39) |
| Etoposide/TBI | 9 (6) | 0 |
| Other | 7 (5) | 7 (3) |
| Unknown | 0 | 21 (9%) |
| Stem-cell source, no. (%) | ||
| BM | 55 (38) | 178 (77) |
| PBSC | 90 (62) | 53 (23) |
Bu indicates busulfan; Cy, cyclophosphamide; TBI, total body irradiation; BM, bone marrow; PBSC, peripheral blood mobilized stem cells.